Assertio Therapeutics

About:

Assertio reflects an aspirational mindset that is forward thinking, energetic, and entrepreneurial in spirit.

Website: http://depomed.com/

Description:

Depomed is a specialty pharmaceutical company that strives to put the patient first in all that they do. Its mission is to improve the lives of patients, families, physicians, providers, and payors by commercializing pain and neurology products and developing drugs for unmet medical needs. Depomed's Neurology and Pain Business currently markets three medicines focused on neuropathic pain and migraine, and it has an emerging Specialty Business focused on orphan drug indications and areas of unmet medical need.

Total Funding Amount:

$42.5M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Newark, California, United States

Founded Date:

1995-01-01

Founders:

John W. Shell

Number of Employees:

251-500

Last Funding Date:

2020-03-11

IPO Status:

Public

Industries:

© 2025 bioDAO.ai